EXTRAINTESTINAL SIGNS, PATHOGENESIS AND GENETIC PREDICTORS OF ULCERATIVE COLITIS

Main Article Content

Maxkamov Mansurjon Maxmudjonovich
Zakirova Umida Irkinovna

Abstract

Ulcerative colitis (UC) is a systemic disease that involves not only the intestine but the whole organism, in which extraintestinal manifestations (EIM) are frequent and in some cases appear before the intestinal symptoms. This article covers the spectrum of EIM in UC (musculoskeletal system, eyes, skin, hepatobiliary system) and modern views on their pathogenesis. Immunological mechanisms - T-cell dysregulation, molecular mimicry, the cytokine flow (TNF-α, IL-1, IL-6) and bacterial translocation associated with disruption of the intestinal barrier - play a leading role in the development of EIM. Genetic predictors include the HLA complex (among them HLA-B27, HLA-DRB10103, HLA-B8/DR3) and HLA-independent loci, as well as the familial concordances reported in GWAS studies. Clinically, UC is noted to be accompanied by peripheral and axial arthritis, enthesitis, osteopenia/osteoporosis and steroid-induced myopathy; ophthalmological complications (episcleritis, uveitis); skin changes (erythema nodosum, pyoderma gangrenosum, Sweet's syndrome), as well as hepatobiliary lesions (primary sclerosing cholangitis, autoimmune hepatitis). The fact that EIM are sometimes independent of intestinal activity complicates diagnosis and treatment. The article demonstrates the importance of multidisciplinary vigilance, early screening, and individualized therapy based on the genetic and clinical phenotype (choice of biological agents). This approach serves to reduce complications and to improve the patient's long-term outcomes.

Article Details

Section

14.00.00 – Medical sciences

How to Cite

EXTRAINTESTINAL SIGNS, PATHOGENESIS AND GENETIC PREDICTORS OF ULCERATIVE COLITIS. (2025). Research Focus International Scientific Journal, 4(8), 61-66. https://doi.org/10.66073/researchfocus.v4i8.1750

References

Danese S, Fiocchi C. Ulcerative colitis. N Engl Med. 2011.

Жахон гастроэнтерология журнали, 2024, №3.

Geng X., Biancone L., Dai H.H. et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colits. Gastroenterology. 1998; 114; 912-922

Biancone L., Mandal A., Yang H. et al. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colits. Gastroenterology. 1995; 109; 3-12

Van Sommeren S., Janse M., Karjalainen J. et al. Extraintestinal manifestation and complications in inflammatory bowel disease: From shared genetics to shared biological pathways. Inflamm. Bowel Dis. 2014; 20: 987-994.

Danese S., Semeraro S., Papa A. et al. Extraintestinal manifestation in inflammatory bowel disease. World J. Gastroenterol. 2005; 11: 7227-7236.

Su C.G., Judge T.A., Lichtenstein G.R. Extraintestinal manifestation in inflammatory bowel disease. World J. Gastroenterol. Clin. North Am. 2002; 31: 307-327.

Roussomoustakaki M., Satsangi J., Welsh K. et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterol. Clin. North Am. 1997; 112: 1845-341.